Your browser doesn't support javascript.
loading
Severe bradycardia: An unreported adverse infusion-associated reaction (IAR) with alemtuzumab.
Nerrant, E; Thouvenot, E; Castelnovo, G.
Afiliação
  • Nerrant E; CHU de Nîmes, Department of Neurology, 9, place du Pr Robert Debré, Nîmes Cedex 9, 30029, France. Electronic address: nerrant.elodie@gmail.com.
  • Thouvenot E; CHU de Nîmes, Department of Neurology, 9, place du Pr Robert Debré, Nîmes Cedex 9, 30029, France; Institut de Génomique Fonctionnelle, Neurosciences, 141, rue de la Cardonille, Montpellier cedex 5, 34294, France.
  • Castelnovo G; CHU de Nîmes, Department of Neurology, 9, place du Pr Robert Debré, Nîmes Cedex 9, 30029, France.
Rev Neurol (Paris) ; 173(3): 175-176, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28320519
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bradicardia / Alemtuzumab Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bradicardia / Alemtuzumab Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2017 Tipo de documento: Article